Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.63 |
| ▸ | TSHR | P16473 | 5/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | APEX1 | P27695 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL2325699 | 0.94 | THRB (0.57) | THRBTSHRALDH1A1TDP1POLB | |
| Phosphoric Acid SCHEMBL867302 | 0.94 | THRB (0.68) | THRBTSHRALDH1A1TDP1POLB | |
| Phosphoric Acid SCHEMBL987870 | 0.92 | THRB (0.55) | THRBTSHRALDH1A1TDP1POLB | |
| Phosphoric Acid SCHEMBL3464242 | 0.91 | TSHR (0.62) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL15636 | 0.90 | THRB (0.74) | THRBTSHRALDH1A1TDP1POLB | |
| SCHEMBL6142874 | 0.90 | THRB (0.74) | THRBTSHRALDH1A1TDP1POLB | |
| Phosphoric Acid SCHEMBL11307097 | 0.90 | THRB (0.53) | THRBTSHRALDH1A1TDP1POLB | |
| Phosphoric Acid SCHEMBL28245746 | 0.90 | THRB (0.53) | THRBTSHRALDH1A1TDP1POLB | |
| Phosphoric Acid SCHEMBL18787889 | 0.90 | THRB (0.53) | THRBTSHRALDH1A1TDP1POLB | |
| Phosphoric Acid SCHEMBL18787890 | 0.90 | THRB (0.53) | THRBTSHRALDH1A1TDP1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3478755-A1 | PHOSPHONATE MODIFIED METAL OXIDE PARTICLE | Dow Global Technologies, LLC (US) | 2019-05-08 | — | — | EP | claimed |
| WO-2018000295-A1 | PHOSPHONATE MODIFIED METAL OXIDE PARTICLE | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-01-04 | — | — | WO | claimed |
| EP-2084216-B1 | RADIATION CURABLE HYBRID COMPOSITION AND PROCESS | CYTEC SURFACE SPECIALTIES SA (BE) | 2013-08-07 | — | — | EP | claimed |
| US-20100075062-A1 | RADIATION CURABLE HYBRID COMPOSITION AND PROCESS | CYTEC SURFACE SPECIALITIES S.A. (BE) | 2010-03-25 | — | — | US | claimed |
| EP-2084216-A1 | RADIATION CURABLE HYBRID COMPOSITION AND PROCESS | Cytec Surface Specialties, S.A. (BE) | 2009-08-05 | — | — | EP | claimed |
| WO-2008058849-A1 | RADIATION CURABLE HYBRID COMPOSITION AND PROCESS | CYTEC SURFACE SPECIALTIES, S.A. (BE) | 2008-05-22 | — | — | WO | claimed |
| US-20050252578-A1 | Process for production of a metal substrate containing a protective coating | PPG INDUSTRIES FRANCE SAS (FR) | 2005-11-17 | — | — | US | claimed |
| WO-2000055391-A1 | TREATING METAL SURFACES | ALBRIGHT & WILSON UK LIMITED (GB) | 2000-09-21 | — | — | WO | claimed |
| EP-0765889-A1 | Polymeric adhesive and flame-retardant compositions | ALBRIGHT & WILSON UK LIMITED (GB) | 1997-04-02 | — | — | EP | claimed |
| US-12233150-B2 | Oral care compositions comprising star-shaped polymers | REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2025-02-25 | — | — | US | disclosed |
| EP-3976204-B1 | ORAL CARE COMPOSITIONS COMPRISING STAR-SHAPED POLYMERS | UNIV MICHIGAN REGENTS (US) | 2024-06-12 | — | — | EP | disclosed |
| WO-2024090510-A1 | MULTILAYER BODY, CURED PRODUCT, PRINTED WIRING BOARD PROVIDED WITH SAID CURED PRODUCT, AND METHOD FOR PRODUCING SAME | 太陽ホールディングス株式会社 | 2024-05-02 | — | — | WO | disclosed |
| US-20230000755-A1 | Oral Care Compositions Comprising Star-Shaped Polymers | COLGATE PALMOLIVE COMPANY | 2023-01-05 | — | — | US | disclosed |
| EP-3976204-A1 | ORAL CARE COMPOSITIONS COMPRISING STAR-SHAPED POLYMERS | The Regents of The University of Michigan (US) | 2022-04-06 | — | — | EP | disclosed |
| WO-2000022016-A1 | LATEX POLYMER COMPOSITIONS | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 2000-04-20 | — | — | WO | disclosed |
| EP-0979854-A1 | CIRCUIT CONNECTING MATERIAL, AND STRUCTURE AND METHOD OF CONNECTING CIRCUIT TERMINAL | HITACHI CHEMICAL COMPANY, LTD. (JP) | 2000-02-16 | — | — | EP | disclosed |
| EP-0784232-A4 | PHOTOSENSITIVE COMPOSITION AND PHOTOSENSITIVE RUBBER PLATE | NIPPON ZEON CO (JP) | 1998-10-21 | — | — | EP | disclosed |
| EP-0765889-A1 | Polymeric adhesive and flame-retardant compositions | ALBRIGHT & WILSON UK LIMITED (GB) | 1997-04-02 | — | — | EP | disclosed |
| EP-0765889-A1 | Polymeric adhesive and flame-retardant compositions | ALBRIGHT & WILSON UK LIMITED (GB) | 1997-04-02 | — | — | EP | disclosed |
| WO-1996010218-A1 | PHOTOSENSITIVE COMPOSITION AND PHOTOSENSITIVE RUBBER PLATE | NIPPON ZEON CO., LTD. (JP) | 1996-04-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12233150-B2 | Oral care compositions comprising star-shaped polymers | STARD7, TAS2R45, KRTCAP2 | THRB 3772/4885TSHR 3645/4885ALDH1A1 3926/4885 |
| US-20230000755-A1 | Oral Care Compositions Comprising Star-Shaped Polymers | STARD7, TAS2R45, KRTCAP2 | THRB 3772/4885TSHR 3645/4885ALDH1A1 3926/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.